ArticleFrontiers in veterinary science2026
Robust cross-immunity against a heterologous field strain of foot-and-mouth disease virus achieved in small ruminants following commercial vaccination in Jordan.
Article in Frontiers in veterinary science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Foot-and-mouth disease (FMD) is a contagious infectious disease, with a severe socio-economic impact, affecting cloven-hoofed livestock. Routine and emergency vaccinations are the most effective tool for the containment and the eradication of the disease in endemic countries. Due to the presence of the virus in seven serotypes and in various lineages and strains, the selection of the most appropriate vaccine is essential to achieve protection. According to WOAH/FAO guidelines, assessing vaccine effectiveness is recommended to improve control strategies. This study reports the analysis of the results from Post Vaccination Monitoring (PVM) performed in Jordan across 2022 and 2023. Methods: A polyvalent inactivated vaccine, including one strain serotype O (O/EURO-SA/O Results: Overall, a single administration of the vaccine was effective in inducing a good response in small ruminants, but a second administration boosted immunity, increasing the level and duration of the immune response in almost all vaccinated animals. The same vaccinal response was apparent when measured against the field strain. Discussion: This field study corroborated the results of vaccine matching and confirmed the current suitability of that particular vaccine formula in the containment of FMD in the Middle East area.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.